
Sign up to save your podcasts
Or


Dr Adam M Brufsky from UPMC Hillman Cancer Center in Pittsburgh summarizes the history of and modern advances in treating localized HER2-positive breast cancers, including strategies for monitoring and managing treatment-related toxicities.
By Dr. Neil Love4.4
6262 ratings
Dr Adam M Brufsky from UPMC Hillman Cancer Center in Pittsburgh summarizes the history of and modern advances in treating localized HER2-positive breast cancers, including strategies for monitoring and managing treatment-related toxicities.

138 Listeners

323 Listeners

498 Listeners

30 Listeners

76 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

121 Listeners

57 Listeners

294 Listeners

3,361 Listeners

205 Listeners

515 Listeners

59 Listeners

193 Listeners

0 Listeners